Ligand Pharmaceuticals (LGND) Notes Payables (2012 - 2019)
Ligand Pharmaceuticals (LGND) posted Notes Payables of $14.3 million for Q2 2019, down 23.46% sequentially from $18.7 million in Q1 2019, and down 96.43% YoY from $401.3 million in Q2 2018.
Ligand Pharmaceuticals (LGND) Notes Payables (2012 - 2019) Analysis & Trends
Ligand Pharmaceuticals has reported Notes Payables for 6 years, with the latest figure at $14.3 million in Q2 2019.
- Quarterly Notes Payables fell 96.43% year-over-year to $14.3 million in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $14.3 million (down 96.43% YoY) and the FY2018 annual result came in at $23.4 million, changed N/A from the prior year.
- Notes Payables eased to $14.3 million in Q2 2019 per LGND's latest filing, from $18.7 million in the prior quarter.
- Over five years, Notes Payables peaked at $563.2 million in Q3 2018 and troughed at $348000.0 in Q1 2015.
- A 3-year average of $170.2 million and a median of $21.1 million in 2018 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2015 and 2019: Notes Payables slumped 93.97% in 2015, then tumbled 96.43% in 2019.
- Over 3 years, Notes Payables stood at $348000.0 in 2015, then surged by 6632.76% to $23.4 million in 2018, then tumbled by 38.91% to $14.3 million in 2019.
- According to Business Quant data, Notes Payables over the past three periods registered $14.3 million, $18.7 million, and $23.4 million for Q2 2019, Q1 2019, and Q4 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ligand Pharmaceuticals | 5.87 Bn | 4.51 Bn | 60.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 14.31 Mn |
| Mar 31, 2019 | 18.70 Mn |
| Dec 31, 2018 | 23.43 Mn |
| Sep 30, 2018 | 563.16 Mn |
| Jun 30, 2018 | 401.29 Mn |
| Mar 31, 2015 | 348,000.00 |
| Dec 31, 2014 | 334,000.00 |
| Sep 30, 2014 | 337,000.00 |
| Jun 30, 2014 | 2.70 Mn |
| Mar 31, 2014 | 5.77 Mn |
| Dec 31, 2013 | 9.11 Mn |
| Sep 30, 2013 | 12.38 Mn |
| Jun 30, 2013 | 13.60 Mn |
| Mar 31, 2013 | 13.21 Mn |
| Dec 31, 2012 | 14.84 Mn |
| Sep 30, 2012 | 10.27 Mn |
| Mar 31, 2012 | 1.44 Mn |